| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000080 | Mitotic g1 phase | Affects phenotype | PMID:29945211 |
| GO:0000084 | Mitotic s phase | Decreases phenotype | PMID:29945211; PMID:32214279 |
| GO:0000085 | Mitotic g2 phase | Decreases phenotype | PMID:32214279 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Increases phenotype | PMID:29945211; PMID:32214279 |
| GO:0001525 | Angiogenesis | Decreases phenotype | PMID:24759048 |
| GO:0001541 | Ovarian follicle development | Affects phenotype | PMID:35031408 |
| GO:0001659 | Temperature homeostasis | Affects phenotype | PMID:30009846 |
| GO:0001818 | Negative regulation of cytokine production | Increases phenotype | PMID:29040392 |
| GO:0001819 | Positive regulation of cytokine production | Increases phenotype | PMID:29040392 |
| GO:0001893 | Maternal placenta development | Decreases phenotype | PMID:38582279 |
| GO:0001894 | Tissue homeostasis | Decreases phenotype | PMID:22147539 |
| GO:0001964 | Startle response | Decreases phenotype | PMID:29020013 |
| GO:0004017 | Adenylate kinase activity | Affects phenotype | PMID:32028016 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:33396045; PMID:35678313 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:33396045; PMID:35678313 |
| GO:0004096 | Catalase activity | Affects phenotype | PMID:33396045 |
| GO:0004197 | Cysteine-type endopeptidase activity | Decreases phenotype | PMID:38040083 |
| GO:0004303 | Estradiol 17-beta-dehydrogenase activity | Decreases phenotype | PMID:34896426 |
| GO:0004364 | Glutathione transferase activity | Increases phenotype | PMID:25816392; PMID:25926273; PMID:33396045 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:23900960; PMID:35678313 |
| GO:0004602 | Glutathione peroxidase activity | Increases phenotype | PMID:25926273; PMID:33396045; PMID:35678313; PMID:35678313 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:23900960; PMID:25816392; PMID:25926273; PMID:35678313 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:33396045; PMID:33396045; PMID:35678313; PMID:35678313 |
| GO:0006701 | Progesterone biosynthetic process | Decreases phenotype | PMID:29253587 |
| GO:0006703 | Estrogen biosynthetic process | Increases phenotype | PMID:29253587 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:28584332; PMID:35876585 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:23900960; PMID:25926273 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:23900960; PMID:25926273; PMID:27704156 |
| GO:0006874 | Cellular calcium ion homeostasis | Decreases phenotype | PMID:26187449; PMID:29149324 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:24810582; PMID:31907151; PMID:32214279; PMID:34714723; PMID:35031408 |
| GO:0007005 | Mitochondrion organization | Affects phenotype | PMID:34794910 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:32028016 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:28731686 |
| GO:0007254 | Jnk cascade | Affects phenotype | PMID:29471534 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:22147539; PMID:34794910; PMID:34896426 |
| GO:0007340 | Acrosome reaction | Decreases phenotype | PMID:33396045; PMID:34896426 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:29253587; PMID:36116546; PMID:37011868; PMID:37011868 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:25370934 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:35678313 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:35031408; PMID:35031408; PMID:36116546; PMID:36116546 |
| GO:0008219 | Cell death | Increases phenotype | PMID:27704156 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:25370934; PMID:25684042; PMID:27704156; PMID:35031408; PMID:36116546; PMID:37011868 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:26877835; PMID:28431163; PMID:28531659 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:29040392; PMID:30974244; PMID:31549662; PMID:36063984 |
| GO:0008306 | Associative learning | Decreases phenotype | PMID:32920670 |
| GO:0008343 | Adult feeding behavior | Affects phenotype | PMID:32006337 |
| GO:0008360 | Regulation of cell shape | Decreases phenotype | PMID:36063984 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Increases phenotype | PMID:35605701 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:35102696; PMID:38040083; PMID:38582279 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:22147539 |
| GO:0010972 | Negative regulation of g2/m transition of mitotic cell cycle | Increases phenotype | PMID:32920670 |
| GO:0010996 | Response to auditory stimulus | Decreases phenotype | PMID:29020013 |
| GO:0014043 | Negative regulation of neuron maturation | Increases phenotype | PMID:32920670 |
| GO:0014054 | Positive regulation of gamma-aminobutyric acid secretion | Increases phenotype | PMID:28975519 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:23900960; PMID:25370934; PMID:25926273; PMID:27704156; PMID:32006337; PMID:33396045; PMID:33396045; PMID:35678313; PMID:35678313 |
| GO:0016887 | Atp hydrolysis activity | Decreases phenotype | PMID:32006337 |
| GO:0019226 | Transmission of nerve impulse | Decreases phenotype | PMID:38599286 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:30738135 |
| GO:0030225 | Macrophage differentiation | Affects phenotype | PMID:29471534 |
| GO:0030283 | Testosterone dehydrogenase [nad(p)] activity | Decreases phenotype | PMID:33396045 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:29471534 |
| GO:0030336 | Negative regulation of cell migration | Increases phenotype | PMID:38582279 |
| GO:0030534 | Adult behavior | Affects phenotype | PMID:29020013; PMID:30009846; PMID:32006337 |
| GO:0031393 | Negative regulation of prostaglandin biosynthetic process | Increases phenotype | PMID:26359731 |
| GO:0031959 | Mineralocorticoid receptor signaling pathway | Increases phenotype | PMID:29149346 |
| GO:0032274 | Gonadotropin secretion | Affects phenotype | PMID:35931855 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:25449125; PMID:26877835 |
| GO:0033327 | Leydig cell differentiation | Decreases phenotype | PMID:35102696 |
| GO:0033686 | Positive regulation of luteinizing hormone secretion | Increases phenotype | PMID:29149324 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:31659573; PMID:35102696; PMID:35876585 |
| GO:0035176 | Social behavior | Affects phenotype | PMID:29020013 |
| GO:0035937 | Estrogen secretion | Increases phenotype | PMID:35931855 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:29020013 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:28655647 |
| GO:0042116 | Macrophage activation | Affects phenotype | PMID:29471534 |
| GO:0042417 | Dopamine metabolic process | Affects phenotype | PMID:32006337 |
| GO:0042428 | Serotonin metabolic process | Affects phenotype | PMID:32006337 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:36116546 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:31659573 |
| GO:0042711 | Maternal behavior | Decreases phenotype | PMID:29020013 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:32920670; PMID:37871686; PMID:38582279 |
| GO:0043068 | Positive regulation of programmed cell death | Increases phenotype | PMID:32920670 |
| GO:0043369 | Cd4-positive or cd8-positive, alpha-beta t cell lineage commitment | Decreases phenotype | PMID:28584332 |
| GO:0043619 | Regulation of transcription from rna polymerase ii promoter in response to oxidative stress | Affects phenotype | PMID:29040392 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:29945211; PMID:31907151; PMID:32028016; PMID:32214279; PMID:32573024; PMID:34714723; PMID:34794910 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:32214279 |
| GO:0045665 | Negative regulation of neuron differentiation | Increases phenotype | PMID:32920670 |
| GO:0045746 | Negative regulation of notch signaling pathway | Increases phenotype | PMID:38582279 |
| GO:0045834 | Positive regulation of lipid metabolic process | Increases phenotype | PMID:35512476 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:21987380; PMID:29945211; PMID:32214279; PMID:36063984 |
| GO:0045992 | Negative regulation of embryonic development | Increases phenotype | PMID:38582279 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:32006337; PMID:35678313 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:22147539 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:28731686 |
| GO:0046661 | Male sex differentiation | Increases phenotype | PMID:28731686 |
| GO:0046697 | Decidualization | Increases phenotype | PMID:36116546 |
| GO:0046881 | Positive regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:29149324 |
| GO:0048060 | Negative gravitaxis | Affects phenotype | PMID:29020013 |
| GO:0048135 | Female germ-line cyst formation | Decreases phenotype | PMID:35031408 |
| GO:0048240 | Sperm capacitation | Decreases phenotype | PMID:33396045; PMID:34896426 |
| GO:0048599 | Oocyte development | Affects phenotype | PMID:35031408 |
| GO:0048711 | Positive regulation of astrocyte differentiation | Increases phenotype | PMID:32920670 |
| GO:0048771 | Tissue remodeling | Decreases phenotype | PMID:37011868 |
| GO:0050765 | Negative regulation of phagocytosis | Increases phenotype | PMID:29040392 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:37871686; PMID:37984602; PMID:38582279 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:30056177; PMID:35931855 |
| GO:0060013 | Righting reflex | Decreases phenotype | PMID:29020013 |
| GO:0060252 | Positive regulation of glial cell proliferation | Increases phenotype | PMID:32920670 |
| GO:0061045 | Negative regulation of wound healing | Increases phenotype | PMID:38582279 |
| GO:0061370 | Testosterone biosynthetic process | Increases phenotype | PMID:28655647; PMID:28731686; PMID:34794910; PMID:34896426; PMID:35031408; PMID:36053783 |
| GO:0070328 | Triglyceride homeostasis | Increases phenotype | PMID:31659573 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Increases phenotype | PMID:29149324 |
| GO:0071425 | Hematopoietic stem cell proliferation | Decreases phenotype | PMID:21987380 |
| GO:0072520 | Seminiferous tubule development | Affects phenotype | PMID:34794910 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:29945211; PMID:31907151; PMID:32028016; PMID:32214279 |
| GO:0090327 | Negative regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:28975519 |
| GO:0090400 | Stress-induced premature senescence | Increases phenotype | PMID:21987380 |
| GO:0097150 | Neuronal stem cell population maintenance | Decreases phenotype | PMID:32920670 |
| GO:0097202 | Activation of cysteine-type endopeptidase activity | Increases phenotype | PMID:32028016 |
| GO:0102727 | 3beta-hydroxysteroid dehydrogenase activity | Decreases phenotype | PMID:33396045; PMID:34896426; PMID:36053783 |
| GO:1901343 | Negative regulation of vasculature development | Increases phenotype | PMID:37984602 |
| GO:1901386 | Negative regulation of voltage-gated calcium channel activity | Increases phenotype | PMID:24913802; PMID:26187449 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:28584332; PMID:31659573; PMID:35876585 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:36063984 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:28584332; PMID:35876585 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Increases phenotype | PMID:31659573 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:29040392; PMID:35102696; PMID:35512476; PMID:37871686; PMID:38582279 |
| GO:1903514 | Release of sequestered calcium ion into cytosol by endoplasmic reticulum | Increases phenotype | PMID:29149324 |
| GO:1903611 | Negative regulation of calcium-dependent atpase activity | Increases phenotype | PMID:29149324 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:37871686 |
| GO:1904879 | Positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | Increases phenotype | PMID:29149324 |
| GO:1990911 | Response to psychosocial stress | Decreases phenotype | PMID:29020013 |
| GO:2000178 | Negative regulation of neural precursor cell proliferation | Increases phenotype | PMID:32920670 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:37984602 |
| GO:2000409 | Positive regulation of t cell extravasation | Increases phenotype | PMID:35512476 |
| GO:2000421 | Positive regulation of eosinophil extravasation | Increases phenotype | PMID:35512476 |
| GO:2000774 | Positive regulation of cellular senescence | Increases phenotype | PMID:36063984 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:22147539; PMID:35102696 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:28731686 |
| GO:2001022 | Positive regulation of response to dna damage stimulus | Increases phenotype | PMID:36063984; PMID:37871686 |
| GO:2001244 | Positive regulation of intrinsic apoptotic signaling pathway | Increases phenotype | PMID:29040392 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.